Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
Bolland W, Michel V, Planas D, Hubert M, Staropoli I, Guivel-Benhassine F, Porrot F, N'Debi M, Rodriguez C, Fourati S, Prot M, Planchais C, Hocqueloux L, Simon-Lorière E, Mouquet H, Prazuck T, Pawlotsky J-M, Bruel T, Schwartz O, Buchrieser J. Bolland W, et al. Among authors: fourati s. J Virol. 2024 Jan 23;98(1):e0135123. doi: 10.1128/jvi.01351-23. Epub 2023 Dec 13. J Virol. 2024. PMID: 38088562 Free PMC article.
MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication.
Ruiz I, Nevers Q, Hernández E, Ahnou N, Brillet R, Softic L, Donati F, Berry F, Hamadat S, Fourati S, Pawlotsky JM, Ahmed-Belkacem A. Ruiz I, et al. Among authors: fourati s. Antimicrob Agents Chemother. 2020 May 21;64(6):e02078-19. doi: 10.1128/AAC.02078-19. Print 2020 May 21. Antimicrob Agents Chemother. 2020. PMID: 32179525 Free PMC article.
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
Softic L, Brillet R, Berry F, Ahnou N, Nevers Q, Morin-Dewaele M, Hamadat S, Bruscella P, Fourati S, Pawlotsky JM, Ahmed-Belkacem A. Softic L, et al. Among authors: fourati s. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00876-20. doi: 10.1128/AAC.00876-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32376613 Free PMC article.
Fitness-associated substitutions following failure of direct-acting antivirals assessed by deep sequencing of full-length hepatitis C virus genomes.
Fourati S, Rodriguez C, Soulier A, Donati F, Hamadat S, Poiteau L, Demontant V, Brillet R, Ahnou N, Gricourt G, Chevaliez S, Ahmed-Belkacem A, Pawlotsky JM. Fourati S, et al. Aliment Pharmacol Ther. 2020 Nov;52(10):1583-1591. doi: 10.1111/apt.16054. Epub 2020 Sep 4. Aliment Pharmacol Ther. 2020. PMID: 32886807
Performance of 22 Rapid Lateral Flow Tests for SARS-CoV-2 Antigen Detection and Influence of "Variants of Concern": Implications for Clinical Use.
Gourgeon A, Soulier A, Audureau É, Khouider S, Galbin A, Langlois C, Bouvier-Alias M, Rodriguez C, Chevaliez S, Pawlotsky JM, Fourati S. Gourgeon A, et al. Among authors: fourati s. Microbiol Spectr. 2022 Aug 31;10(4):e0115722. doi: 10.1128/spectrum.01157-22. Epub 2022 Jul 12. Microbiol Spectr. 2022. PMID: 35862982 Free PMC article.
SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study.
Fourati S, Audureau E, Arrestier R, Marot S, Dubois C, Voiriot G, Luyt CE, Urbina T, Mayaux J, Roque-Afonso AM, Pham T, Landraud L, Visseaux B, Roux D, Bellaiche R, L'honneur AS, Ait Hamou Z, Brichler S, Gaudry S, Salmona M, Clere-Jehl R, Azoulay E, Morand-Joubert L, Marcelin AG, Chaix ML, Descamps D, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, de Prost N. Fourati S, et al. Viruses. 2022 Jul 13;14(7):1529. doi: 10.3390/v14071529. Viruses. 2022. PMID: 35891509 Free PMC article.
Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
Ahmed-Belkacem A, Redjoul R, Brillet R, Ahnou N, Leclerc M, López-Molina DS, Soulier A, Gourgeon A, Rodriguez C, Maury S, Pawlotsky JM, Fourati S. Ahmed-Belkacem A, et al. Among authors: fourati s. Viruses. 2022 Aug 30;14(9):1928. doi: 10.3390/v14091928. Viruses. 2022. PMID: 36146735 Free PMC article.
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
de Prost N, Audureau E, Heming N, Gault E, Pham T, Chaghouri A, de Montmollin N, Voiriot G, Morand-Joubert L, Joseph A, Chaix ML, Préau S, Favory R, Guigon A, Luyt CE, Burrel S, Mayaux J, Marot S, Roux D, Descamps D, Meireles S, Pène F, Rozenberg F, Contou D, Henry A, Gaudry S, Brichler S, Timsit JF, Kimmoun A, Hartard C, Jandeaux LM, Fafi-Kremer S, Gabarre P, Emery M, Garcia-Sanchez C, Jochmans S, Pitsch A, Annane D, Azoulay E, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S. de Prost N, et al. Among authors: fourati s. Nat Commun. 2022 Dec 7;13(1):7547. doi: 10.1038/s41467-022-34575-0. Nat Commun. 2022. PMID: 36477670 Free PMC article. No abstract available.
SARS-CoV-2 variants and mutational patterns: relationship with risk of ventilator-associated pneumonia in critically ill COVID-19 patients in the era of dexamethasone.
Razazi K, Martins Bexiga A, Arrestier R, Peiffer B, Voiriot G, Luyt CE, Urbina T, Mayaux J, Pham T, Roux D, Bellaiche R, AIt Hamou Z, Gaudry S, Azoulay E, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S, de Prost N. Razazi K, et al. Among authors: fourati s. Sci Rep. 2023 Apr 24;13(1):6658. doi: 10.1038/s41598-023-33639-5. Sci Rep. 2023. PMID: 37095145 Free PMC article.
235 results